Global ENT Devices Market Analysis and Forecast, 2021-2022 & 2030 – Opportunities for Synergies Between Local Health Authorities and Leading Medical Device Companies – ResearchAndMarkets.com


DUBLIN–(BUSINESS WIRE)–The report “ENT Devices Market – A Global and Regional Analysis: Focus on Procedure, End User, Product Type and Country Analysis – Analysis and Forecast, 2021-2030” has been added to from ResearchAndMarkets.com offer.

The Global ENT Devices Market report highlights that the market was valued at USD 13,799.5 million in 2020 and is projected to reach USD 25,127.7 million by the end of 2030.

The market is expected to grow at a CAGR of 6.12% during the forecast period of 2021 to 2030.

Global ENT Devices Market Overview

ENT devices are used to diagnose and treat various ear, nose and throat disorders. Devices can be categorized into diagnostic devices, surgical devices, viewing devices, hearing aids, surgical razors and debriders, and others.

The global ENT device market is witnessing a high degree of technological integration over the past few years. The market includes various key medical device companies and local businesses. Major factors that are positively impacting the growth of the market include increasing prevalence of hearing disorders, increasing integration of technology in ENT devices, and increasing preference for minimally invasive procedures in ENT specialty.

During COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the market recovered rapidly in the last quarter of 2020 and the integration of telehealth in the ENT specialty had a positive impact of COVID-19 on the market.

Global ENT Devices Market Drivers

Factors driving the growth of the market include increasing prevalence of hearing disorders, growing integration of technology in ENT devices, and increasing preference for minimally invasive procedures in ENT specialty. The increasing prevalence of hearing disorders is the major market driver in both established and emerging economies.

For example, according to a study published in The Lancet in March 2021, titled “Hearing Loss Prevalence and Years Lived with Disability, 1990-2019: Findings from The Global Burden of Disease Study 2019”, an estimated 1.5 billion people suffered from disability. auditory. in the world in 2019. This implies that one in five people suffer from some form of hearing loss worldwide.

Additionally, hearing impairment is the third most common factor for years lived with disability (YLD) in the global population. The prevalence of hearing loss is expected to increase over the next decade. According to the World Health Organization (WHO), the number of people with disabling hearing loss (DHL) could reach 630 million in 2030 and over 900 million by 2050.

Hence, the increasing prevalence of hearing disorders will propel the adoption of hearing aid treatments and advance the growth of the global ENT devices market.

Global ENT Devices Market Challenges

Factors limiting the growth of the global ENT devices market include the high cost of ENT procedures and the social stigma associated with hearing disorders. The high cost has limited the volume of the procedure in emerging and developed economies.

For example, according to a study published in NCBI in 2018 titled “Health Care Costs and Cost-Effectiveness of Laryngotracheal Stenosis,” treatment of laryngotracheal stenosis (LTS) is one of the expensive ENT procedures. The average annual cost associated with the disease was $4,080.09.

Furthermore, according to another study titled “Comparing the Financial Burden of Head and Neck Cancer Survivors with Other Cancer Survivors,” published in March 2019, patients receiving treatment for head and neck cancer neck bear higher expenses compared to other cancers. the patients. In addition, these patients incur higher costs.

Thus, high cost of procedures and lack of reimbursement are hindering the growth of the global ENT devices market.

Global ENT Devices Market Opportunities

The emergence of regional ENT device manufacturers and synergies between local health authorities and major medical device companies are the major opportunities in the global ENT device market.

Key companies operating in the market can expand in emerging economies by partnering with local health authorities. These synergies will allow companies to effectively penetrate markets and expand their customer base.

For example, Cochlear Limited partnered with the Royal Victorian Eye and Ear Hospital in the UK for the development of the Geelong Cochlear Care Centre. The center is Cochlear Limited’s first care center in the UK and is expected to enhance the company’s presence in the country.

Impact of COVID-19 on the Global ENT Devices Market

During COVID-19, the growth of the ENT Devices market was negatively impacted, especially in 2020. Although ENT facilities continued to operate, business sales were negatively impacted.

Nevertheless, the market grew little in 2020 and is expected to witness considerable growth over the forecast period 2021-2030. Rising technological innovations in the global market and rising adoption in emerging economies are the driving forces behind the market.

Key Market Players and Competition Summary

Some of the strategies covered in this segment are financing activities, mergers and acquisitions (M&A), partnerships, alliances and business expansion, regulatory and legal activities and new offerings. The preferred strategy for companies has been the launch of new products or new offerings followed by partnerships, alliances and commercial expansion.

Market segmentation

  • Type of Procedure – Flexible transoral and transnasal procedures (diagnostic and interventional), turbinate reduction and endoscopic polyp removal, and tympanostomies and airway tube operations

  • End user – Hospitals, ENT clinics, outpatient centers and others

  • Product Type – Diagnostic Devices, Surgical Devices, Hearing Aids, Visualization Devices, Surgical Razors & Debriders, and Others

Industry Outlook

Technological landscape

Key trends

  • Opportunity assessment

  • Short term potential

  • Long term potential

Patent analysis

  • Growth trend in patent publications

  • Analysis of patents by country/cluster

  • Product Benchmarking

  • Ongoing clinical trial studies

Impact of COVID-19 on the Global ENT Devices Market

  • Impact on facilities

  • Impact on device adoption

  • Impact on market size

  • Pre-COVID-19 phase

  • During the COVID-19 phase

  • Post-COVID-19 phase

Market analysis

Exoscope market

  • Market size and forecast

  • By region

  • By app

  • By ENT Procedures

Comparative analysis

  • Headlights Market Vs. Surgical Loop Market

  • Endoscopic Ear Surgery Vs. Open Surgeries

  • Volume of the procedure

  • Market size

Commercial dynamics

Business drivers

  • Increasing prevalence of hearing impairment

  • Increasing technological integration in ENT devices

  • Growing preference for minimally invasive procedures in the ENT specialty

Commercial constraints

  • High cost of ENT procedures

  • Social stigma associated with hearing impairment

Professional opportunities

  • Emergence of regional ENT device manufacturers

  • Synergies between local health authorities and leading medical device companies

Company Profiles

  • Ambu A/S

  • Atos Medical AB

  • Boston Scientific Society

  • Cochlear Limited

  • Applicant A/S

  • Eckert & Ziegler BEBIG AG

  • HOYA Company

  • Johnson & Johnson

  • KARL STORZ SE & Co. KG

  • Medtronic plc

  • Olympus Society

  • Richard Wolf GmbH

  • Smith & Nephew Plc

  • Sonova Holding AG

  • Stryker Company

For more information about this report visit https://www.researchandmarkets.com/r/ojj6ti

Previous Japan's inflation driven by energy and commodity costs, says PM Kishida By Reuters
Next Hannah Vogler will succeed Dr. Suzanne Mitchell at the Arkansas STEM Coalition